BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33275968)

  • 1. Visualizing the Dynamics of a Protein Folding Machinery: The Mechanism of Asymmetric ATP Processing in Hsp90 and its Implications for Client Remodelling.
    D'Annessa I; Moroni E; Colombo G
    J Mol Biol; 2021 Jan; 433(2):166728. PubMed ID: 33275968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atomistic simulations and network-based modeling of the Hsp90-Cdc37 chaperone binding with Cdk4 client protein: A mechanism of chaperoning kinase clients by exploiting weak spots of intrinsically dynamic kinase domains.
    Czemeres J; Buse K; Verkhivker GM
    PLoS One; 2017; 12(12):e0190267. PubMed ID: 29267381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional Role and Hierarchy of the Intermolecular Interactions in Binding of Protein Kinase Clients to the Hsp90-Cdc37 Chaperone: Structure-Based Network Modeling of Allosteric Regulation.
    Stetz G; Verkhivker GM
    J Chem Inf Model; 2018 Feb; 58(2):405-421. PubMed ID: 29432007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Mechanism of Hsp90 regulation by the protein kinase-specific cochaperone p50(cdc37).
    Roe SM; Ali MM; Meyer P; Vaughan CK; Panaretou B; Piper PW; Prodromou C; Pearl LH
    Cell; 2004 Jan; 116(1):87-98. PubMed ID: 14718169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Client-loading conformation of the Hsp90 molecular chaperone revealed in the cryo-EM structure of the human Hsp90:Hop complex.
    Southworth DR; Agard DA
    Mol Cell; 2011 Jun; 42(6):771-81. PubMed ID: 21700222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket.
    Donnelly A; Blagg BS
    Curr Med Chem; 2008; 15(26):2702-17. PubMed ID: 18991631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational dynamics modulate the catalytic activity of the molecular chaperone Hsp90.
    Mader SL; Lopez A; Lawatscheck J; Luo Q; Rutz DA; Gamiz-Hernandez AP; Sattler M; Buchner J; Kaila VRI
    Nat Commun; 2020 Mar; 11(1):1410. PubMed ID: 32179743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic Asymmetry in Hsp90 Dimers.
    Flynn JM; Mishra P; Bolon DN
    J Mol Biol; 2015 Sep; 427(18):2904-11. PubMed ID: 25843003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric regulation of the Hsp90 dynamics and stability by client recruiter cochaperones: protein structure network modeling.
    Blacklock K; Verkhivker GM
    PLoS One; 2014; 9(1):e86547. PubMed ID: 24466147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hsp90/Cdc37 chaperone/co-chaperone complex, a novel junction anticancer target elucidated by the mode of action of herbal drug Withaferin A.
    Grover A; Shandilya A; Agrawal V; Pratik P; Bhasme D; Bisaria VS; Sundar D
    BMC Bioinformatics; 2011 Feb; 12 Suppl 1(Suppl 1):S30. PubMed ID: 21342561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A primate specific extra domain in the molecular chaperone Hsp90.
    Tripathi V; Obermann WM
    PLoS One; 2013; 8(8):e71856. PubMed ID: 23951259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteins.
    Smith JR; de Billy E; Hobbs S; Powers M; Prodromou C; Pearl L; Clarke PA; Workman P
    Oncogene; 2015 Jan; 34(1):15-26. PubMed ID: 24292678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novobiocin induces a distinct conformation of Hsp90 and alters Hsp90-cochaperone-client interactions.
    Yun BG; Huang W; Leach N; Hartson SD; Matts RL
    Biochemistry; 2004 Jun; 43(25):8217-29. PubMed ID: 15209518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimentally guided structural modeling and dynamics analysis of Hsp90-p53 interactions: allosteric regulation of the Hsp90 chaperone by a client protein.
    Blacklock K; Verkhivker GM
    J Chem Inf Model; 2013 Nov; 53(11):2962-78. PubMed ID: 24191708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hsp90·Cdc37 Complexes with Protein Kinases Form Cooperatively with Multiple Distinct Interaction Sites.
    Eckl JM; Scherr MJ; Freiburger L; Daake MA; Sattler M; Richter K
    J Biol Chem; 2015 Dec; 290(52):30843-54. PubMed ID: 26511315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cdc37-Hsp90 complexes are responsive to nucleotide-induced conformational changes and binding of further cofactors.
    Gaiser AM; Kretzschmar A; Richter K
    J Biol Chem; 2010 Dec; 285(52):40921-32. PubMed ID: 20880838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleotide-Free sB-Raf is Preferentially Bound by Hsp90 and Cdc37 In Vitro.
    Eckl JM; Daake M; Schwartz S; Richter K
    J Mol Biol; 2016 Oct; 428(20):4185-4196. PubMed ID: 27620500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of the weak ATPase activity of human hsp90 by a client protein.
    McLaughlin SH; Smith HW; Jackson SE
    J Mol Biol; 2002 Jan; 315(4):787-98. PubMed ID: 11812147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring Mechanisms of Allosteric Regulation and Communication Switching in the Multiprotein Regulatory Complexes of the Hsp90 Chaperone with Cochaperones and Client Proteins: Atomistic Insights from Integrative Biophysical Modeling and Network Analysis of Conformational Landscapes.
    Verkhivker GM
    J Mol Biol; 2022 Sep; 434(17):167506. PubMed ID: 35202628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation induced cochaperone unfolding promotes kinase recruitment and client class-specific Hsp90 phosphorylation.
    Bachman AB; Keramisanou D; Xu W; Beebe K; Moses MA; Vasantha Kumar MV; Gray G; Noor RE; van der Vaart A; Neckers L; Gelis I
    Nat Commun; 2018 Jan; 9(1):265. PubMed ID: 29343704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.